Literature DB >> 23868114

Metabolic disease: potassium channel blocker prevents obesity.

Sarah Crunkhorn.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23868114     DOI： 10.1038/nrd4081

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN： 1474-1776            Impact factor:   84.694


× No keyword cloud information.
  1 in total

1.  Selective Kv1.3 channel blocker as therapeutic for obesity and insulin resistance.

Authors:  Sanjeev Kumar Upadhyay; Kristin L Eckel-Mahan; M Reza Mirbolooki; Indra Tjong; Stephen M Griffey; Galina Schmunk; Amanda Koehne; Briac Halbout; Shawn Iadonato; Brian Pedersen; Emiliana Borrelli; Ping H Wang; Jogeshwar Mukherjee; Paolo Sassone-Corsi; K George Chandy
Journal:  Proc Natl Acad Sci U S A       Date:  2013-05-31       Impact factor: 11.205
  1 in total
  3 in total

Review 1.  Potassium and Obesity/Metabolic Syndrome: A Systematic Review and Meta-Analysis of the Epidemiological Evidence.

Authors:  Xianlei Cai; Xueying Li; Wenjie Fan; Wanqi Yu; Shan Wang; Zhenhong Li; Ethel Marian Scott; Xiuyang Li
Journal:  Nutrients       Date:  2016-03-25       Impact factor: 5.717

2.  Sodium and potassium intakes and adiposity among Iranian pre-adolescents and adolescents: a cross-sectional study.

Authors:  Sahar Golpour-Hamedani; Nahid Rafie; Makan Pourmasoumi; Sayyed Morteza Safavi; Noushin Mohammadifard
Journal:  Nutr J       Date:  2022-04-28       Impact factor: 4.344

3.  An integrative study identifies KCNC2 as a novel predisposing factor for childhood obesity and the risk of diabetes in the Korean population.

Authors:  Joo-Yeon Hwang; Hyo Jung Lee; Min Jin Go; Han Byul Jang; Sang Ick Park; Bong-Jo Kim; Hye-Ja Lee
Journal:  Sci Rep       Date:  2016-09-14       Impact factor: 4.379
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.